CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale · Change in control · Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 8-K Event Delisting notice
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Auditor change · Executive or director change
- 4 Insider Changes in Ownership
- PRER14A Other PRER14A
- 8-K Event Auditor change
- 8-K Event Director nominations · Other events
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 3 of 34 · 676 filings